Metabolic profiling of streptomyces strains from different types of Tatarstan soils using GEN III omnilog system

Isolation and evaluation of the ability of various actinomycetes to produce bioactive secondary metabolites is a long-term and expensive procedure. Many species of actinomycetes have similar morphological characteristics, therefore phenotyping of these microorganisms requires methods of metabolic profiling to be applied. Analysis of metabolic pathways can help in both the taxonomic identification of a microorganism and the assessment of its ability to produce a variety of secondary metabolites. In this paper, we first carried out metabolic profiling of Streptomyces isolates from different types of Tatarstan soils using GEN III OmniLog system. We also performed a phylogenetic analysis of strains. We assigned strains to the genus Streptomyces, and identified species such as Streptomyces fimicarius, Streptomyces badius, Streptomyces mirabilis and Streptomyces violaceoruber. We have shown that the system GEN III OmniLog® II Combo Plus is a powerful tool to get an overview of the active metabolic pathways of actinomycetes and can be used for high-performance analysis. It can also provide useful information to clarify the phylogenetic position of a microorganism. We can use both the profiles of substrate utilization, growth, secondary metabolites, and anti-microbial profiles, obtained by using the GEN III OmniLog® II Combo Plus system, in the microbial drug development programs

Metabolic profiling of streptomyces strains from different types of Tatarstan soils using GEN III omnilog system

Isolation and evaluation of the ability of various actinomycetes to produce bioactive secondary metabolites is a long-term and expensive procedure. Many species of actinomycetes have similar morphological characteristics, therefore phenotyping of these microorganisms requires methods of metabolic profiling to be applied. Analysis of metabolic pathways can help in both the taxonomic identification of a microorganism and the assessment of its ability to produce a variety of secondary metabolites. In this paper, we first carried out metabolic profiling of Streptomyces isolates from different types of Tatarstan soils using GEN III OmniLog system. We also performed a phylogenetic analysis of strains. We assigned strains to the genus Streptomyces, and identified species such as Streptomyces fimicarius, Streptomyces badius, Streptomyces mirabilis and Streptomyces violaceoruber. We have shown that the system GEN III OmniLog® II Combo Plus is a powerful tool to get an overview of the active metabolic pathways of actinomycetes and can be used for high-performance analysis. It can also provide useful information to clarify the phylogenetic position of a microorganism. We can use both the profiles of substrate utilization, growth, secondary metabolites, and anti-microbial profiles, obtained by using the GEN III OmniLog® II Combo Plus system, in the microbial drug development programs

Metabolic profiling of streptomyces strains from different types of Tatarstan soils using GEN III omnilog system

Isolation and evaluation of the ability of various actinomycetes to produce bioactive secondary metabolites is a long-term and expensive procedure. Many species of actinomycetes have similar morphological characteristics, therefore phenotyping of these microorganisms requires methods of metabolic profiling to be applied. Analysis of metabolic pathways can help in both the taxonomic identification of a microorganism and the assessment of its ability to produce a variety of secondary metabolites. In this paper, we first carried out metabolic profiling of Streptomyces isolates from different types of Tatarstan soils using GEN III OmniLog system. We also performed a phylogenetic analysis of strains. We assigned strains to the genus Streptomyces, and identified species such as Streptomyces fimicarius, Streptomyces badius, Streptomyces mirabilis and Streptomyces violaceoruber. We have shown that the system GEN III OmniLog® II Combo Plus is a powerful tool to get an overview of the active metabolic pathways of actinomycetes and can be used for high-performance analysis. It can also provide useful information to clarify the phylogenetic position of a microorganism. We can use both the profiles of substrate utilization, growth, secondary metabolites, and anti-microbial profiles, obtained by using the GEN III OmniLog® II Combo Plus system, in the microbial drug development programs

Metabolic profiling of streptomyces strains from different types of Tatarstan soils using GEN III omnilog system

Isolation and evaluation of the ability of various actinomycetes to produce bioactive secondary metabolites is a long-term and expensive procedure. Many species of actinomycetes have similar morphological characteristics, therefore phenotyping of these microorganisms requires methods of metabolic profiling to be applied. Analysis of metabolic pathways can help in both the taxonomic identification of a microorganism and the assessment of its ability to produce a variety of secondary metabolites. In this paper, we first carried out metabolic profiling of Streptomyces isolates from different types of Tatarstan soils using GEN III OmniLog system. We also performed a phylogenetic analysis of strains. We assigned strains to the genus Streptomyces, and identified species such as Streptomyces fimicarius, Streptomyces badius, Streptomyces mirabilis and Streptomyces violaceoruber. We have shown that the system GEN III OmniLog® II Combo Plus is a powerful tool to get an overview of the active metabolic pathways of actinomycetes and can be used for high-performance analysis. It can also provide useful information to clarify the phylogenetic position of a microorganism. We can use both the profiles of substrate utilization, growth, secondary metabolites, and anti-microbial profiles, obtained by using the GEN III OmniLog® II Combo Plus system, in the microbial drug development programs

Role of a<inf>2</inf>-adrenoceptors in rat heart with the model of myocardial infarction

Chronic adrenergic and angiotensin-energic stimulation of the heart muscle is one of the main causes of the onset and development of heart failure. α2-AR is widespread in the cardiovascular system and can be further applied and introduced into the heart's regenerative cell therapy. This study's objective was to study the effect of α2-AR stimulation on the performance of an isolated heart in rats with a model of myocardial infarction. To study the mechanisms of MI, experiments were carried out according to the classical technique of H. Selye-ligation of the anterior branch of the left coronary artery and perfusion of a Langendorff heart with a model of myocardial infarction. We studied the parameters of myocardial activity by changes in heart rate, as well as the left ventricle pressure (LVP), and the CF (dp/dtmax)/(dp/dtmin) of the left ventricle. Coronary dilator activity was assessed by measuring the outflow of the perfusion solution through the coronary arteries. The amplitude of the left ventricle's pressure wave after application of the α2-AR agonist clonidine hydrochloride at a concentration of 10-6 M to the perfused solution increased by 44% (p≤0.05) from the initial values. The rate of contraction and the rate of relaxation of the left ventricular myocardium also increased by 20% (p≤0.05) and 37% (p≤0.05), respectively. The activation of α2-AR in adult rats' isolated hearts with a model of myocardial infarction caused a decrease in heart rate by 18% (p≤0.05) and CF by 2% (p≤0.05)